Acorah Software Products - Accounts Production 16.6.950 false true 31 May 2024 1 June 2023 false 1 June 2024 31 May 2025 31 May 2025 12596850 Mr HASSAN BHATTI iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 12596850 2024-05-31 12596850 2025-05-31 12596850 2024-06-01 2025-05-31 12596850 frs-core:Non-currentFinancialInstruments 2025-05-31 12596850 frs-core:ShareCapital 2025-05-31 12596850 frs-core:RetainedEarningsAccumulatedLosses 2025-05-31 12596850 frs-bus:PrivateLimitedCompanyLtd 2024-06-01 2025-05-31 12596850 frs-bus:FilletedAccounts 2024-06-01 2025-05-31 12596850 frs-bus:SmallEntities 2024-06-01 2025-05-31 12596850 frs-bus:AuditExempt-NoAccountantsReport 2024-06-01 2025-05-31 12596850 frs-bus:SmallCompaniesRegimeForAccounts 2024-06-01 2025-05-31 12596850 frs-bus:Director1 2024-06-01 2025-05-31 12596850 frs-countries:EnglandWales 2024-06-01 2025-05-31 12596850 2023-05-31 12596850 2024-05-31 12596850 2023-06-01 2024-05-31 12596850 frs-core:CurrentFinancialInstruments 2024-05-31 12596850 frs-core:Non-currentFinancialInstruments 2024-05-31 12596850 frs-core:ShareCapital 2024-05-31 12596850 frs-core:RetainedEarningsAccumulatedLosses 2024-05-31
Registered number: 12596850
ELIZABETHPHARMA LTD
Unaudited Financial Statements
For The Year Ended 31 May 2025
NI Accountants
7 New Street
Dudley
West Midlands
DY1 1LT
ELIZABETHPHARMA LTD
Contents
Contents

| Page
--- | ---
Balance Sheet | 1
Notes to the Financial Statements | 2

Page 1
ELIZABETHPHARMA LTD
Balance Sheet
As At 31 May 2025
Balance Sheet
Registered number: 12596850

| 2025 | 2024
--- | --- | ---
| Notes | £ | £ | £ | £
CURRENT ASSETS
Cash at bank and in hand |  | 42,674 |  | 42,675 |
|  | 42,674 |  | 42,675 |
Creditors: Amounts Falling Due Within One Year | 4 | - |  | (1 ) |
NET CURRENT ASSETS (LIABILITIES) |  |  | 42,674 |  | 42,674
TOTAL ASSETS LESS CURRENT LIABILITIES |  |  | 42,674 |  | 42,674
Creditors: Amounts Falling Due After More Than One Year | 5 |  | (184 ) |  | -
NET ASSETS |  |  | 42,490 |  | 42,674
CAPITAL AND RESERVES
Called up share capital | 6 |  | 1 |  | 1
Profit and Loss Account |  |  | 42,489 |  | 42,673
SHAREHOLDERS' FUNDS |  |  | 42,490 |  | 42,674

For the year ending 31 May 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The member has not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
The company has taken advantage of section 444(1) of the Companies Act 2006 and opted not to deliver to the registrar a copy of the company's Profit and Loss Account.
On behalf of the board

Mr HASSAN BHATTI Director
24/02/2026

The notes on page 2 form part of these financial statements.
Page 1
Page 2
ELIZABETHPHARMA LTD
Notes to the Financial Statements
For The Year Ended 31 May 2025
Notes to the Financial Statements
1. General Information
ELIZABETHPHARMA LTD is a private company, limited by shares, incorporated in England & Wales, registered number 12596850 . The registered office is 84 Rowan Crescent, Wolverhampton, West Midlands, WV3 7HL.
2. Accounting Policies
2.1. Basis of Preparation of Financial Statements
The financial statements have been prepared under the historical cost convention and in accordance with Financial Reporting Standard 102 section 1A Small Entities "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Companies Act 2006.
2.2. Turnover
Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the sale of goods and from the rendering of services. Turnover is reduced for estimated customer returns, rebates and other similar allowances.
Sale of goods
Turnover from the sale of goods is recognised when the significant risks and rewards of ownership of the goods has transferred to the buyer. This is usually at the point that the customer has signed for the delivery of the goods.
Rendering of services
Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs. Turnover is only recognised to the extent of recoverable expenses when the outcome of a contract cannot be estimated reliably.
3. Average Number of Employees
Average number of employees, including directors, during the year was: NIL (2024: 1)
- 1
4. Creditors: Amounts Falling Due Within One Year

| 2025 |  | 2024
--- | --- | --- | ---
| £ |  | £
Trade creditors | - |  | 1

5. Creditors: Amounts Falling Due After More Than One Year

| 2025 |  | 2024
--- | --- | --- | ---
| £ |  | £
Directors loan account | 184 |  | -

6. Share Capital

| 2025 |  | 2024
--- | --- | --- | ---
| £ |  | £
Allotted, Called up and fully paid | 1 |  | 1

Page 2